MENU
CRIS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Curis (CRIS) Ownership - Who owns Curis?
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
128 Spring Street
Phone
+1 617 503-6500
Employees
49
Web
https://www.curis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
21.62M
P/E Ratio
N/A
Total Cash
10.14M
Projected Growth
N/A
Total Debt
2.31M
Revenue
11.41M
Risk (Beta)
4.38
Dividend Yield
N/A
Total Cash/Share
0.81
Total Debt/Equity
74.54
Revenue/Share
1.31 USD as % of share price
Fundamentals
CRIS
Capitalization
21.6M
P/E Ratio
N/A
Risk (Beta)
4.38
Dividend Yield
N/A
Total Cash
10.1M
Total Cash/Share
0.81
Total Debt
2.31M
Total Debt/Equity
74.54
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.31%
Revenue
11.4M
ROE
N/A
Book Value
-13.99M
P/B Ratio
3.41
Cash Flow
N/A
Earnings
-4.62
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
107K
Current Ratio
0.74
Current Revenue Per Employee
83303.03
Dividends Per Share - Security
N/A
EBITDA
-36.02M
Float
N/A
Float - Current
N/A
Gross Income Margin
99.42
Revenue To Assets
-97.73
Shares Held By Institutions
84.8M
Shares Outstanding - Current
12.5M
Total Liabilities
43.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-43.791
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a drug company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
128 Spring Street
Phone
+1 617 503-6500
Employees
49
Web
https://www.curis.com